|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.12 EUR | -1.24% |
|
-1.66% | -27.14% |
| 09:31am | Germany's VCI forecasts a 'difficult path', chemical industry stagnating in 2026 | RE |
| 12-09 | Crisis in East German Chemical Industry - "Chemistry Summit" Planned in Böhlen | DP |
| Capitalization | 1.5B 1.74B 1.4B 1.31B 2.41B 157B 2.62B 16.29B 6.33B 74.21B 6.54B 6.4B 273B | P/E ratio 2025 * |
-6.17x | P/E ratio 2026 * | -11.6x |
|---|---|---|---|---|---|
| Enterprise value | 3.55B 4.13B 3.33B 3.1B 5.71B 371B 6.21B 38.62B 15.01B 176B 15.5B 15.18B 648B | EV / Sales 2025 * |
0.62x | EV / Sales 2026 * | 0.6x |
| Free-Float |
94.86% | Yield 2025 * |
0.58% | Yield 2026 * | 0.8% |
Last Transcript: LANXESS AG
| 1 day | -1.36% | ||
| 1 week | -1.66% | ||
| Current month | -1.66% | ||
| 3 months | -25.30% | ||
| 6 months | -37.30% | ||
| Current year | -27.14% |
| 1 week | 16.87 | 17.57 | |
| 1 month | 15.65 | 18.19 | |
| Current year | 15.65 | 33.93 | |
| 1 year | 15.65 | 33.93 | |
| 3 years | 15.65 | 47.83 | |
| 5 years | 15.65 | 67.38 | |
| 10 years | 15.65 | 74.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthias Zachert
CEO | Chief Executive Officer | 58 | 31/03/2014 |
Oliver Stratmann
DFI | Director of Finance/CFO | 53 | 31/08/2023 |
Eva Frerker
IRC | Investor Relations Contact | - | 31/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 23/05/2024 | |
Lawrence Rosen
BRD | Director/Board Member | 68 | 12/05/2015 |
Manuela Strauch
BRD | Director/Board Member | 54 | 31/12/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.24% | -1.66% | -35.29% | -52.06% | 1.74B | ||
| +0.25% | +2.46% | -13.12% | +40.32% | 57.14B | ||
| -0.27% | -2.69% | -4.23% | -7.86% | 44.7B | ||
| -0.28% | -1.55% | -9.39% | +8.30% | 16.53B | ||
| 0.00% | +8.37% | +29.99% | +39.29% | 12.05B | ||
| +1.12% | +3.46% | +24.83% | +25.09% | 9.55B | ||
| -0.44% | -0.67% | -12.35% | - | 8.1B | ||
| -1.08% | -2.70% | -23.58% | -20.00% | 8.1B | ||
| +1.96% | +1.76% | +10.00% | +21.47% | 7.41B | ||
| +0.84% | +1.05% | -11.11% | -8.75% | 5.15B | ||
| Average | +0.07% | +0.06% | -4.43% | +5.09% | 17.05B | |
| Weighted average by Cap. | +0.05% | -0.25% | -4.88% | +16.41% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.75B 6.7B 5.4B 5.03B 9.26B 602B 10.06B 62.59B 24.33B 285B 25.13B 24.59B 1,051B | 5.77B 6.72B 5.41B 5.04B 9.29B 603B 10.1B 62.78B 24.4B 286B 25.2B 24.67B 1,054B |
| Net income | -251M -292M -236M -220M -405M -26.28B -440M -2.73B -1.06B -12.46B -1.1B -1.07B -45.89B | -118M -138M -111M -103M -190M -12.37B -207M -1.29B -500M -5.86B -517M -506M -21.6B |
| Net Debt | 2.05B 2.39B 1.93B 1.79B 3.3B 215B 3.59B 22.33B 8.68B 102B 8.97B 8.78B 375B | 1.98B 2.31B 1.86B 1.73B 3.19B 207B 3.47B 21.56B 8.38B 98.21B 8.65B 8.47B 362B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/25 | 17.18 € | -0.92% | 107,727 |
| 09/12/25 | 17.34 € | +1.40% | 472,062 |
| 08/12/25 | 17.10 € | -1.38% | 464,530 |
| 05/12/25 | 17.34 € | +1.70% | 526,865 |
| 04/12/25 | 17.05 € | -2.40% | 491,522 |
Delayed Quote Xetra, December 10, 2025 at 12:13 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LXS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















